Overview

Low Dose Apomorphine and Parkinsonism

Status:
Withdrawn
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if low doses of apomorphine worsen the motor symptoms of Parkinson's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Apomorphine